High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer (Q43980571)

28 November 2017

title

High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer (English)

1 reference

28 November 2017

Motohiro Imano

1

1 reference

28 November 2017

Tatsuki Itoh

2

1 reference

28 November 2017

Takao Satou

3

1 reference

28 November 2017

Atsushi Yasuda

4

1 reference

28 November 2017

Kohei Nishiki

5

1 reference

28 November 2017

Hiroaki Kato

6

1 reference

28 November 2017

Osamu Shiraishi

7

1 reference

28 November 2017

Ying-Feng Peng

8

1 reference

28 November 2017

Masayuki Shinkai

9

1 reference

28 November 2017

Masahiro Tsubaki

10

1 reference

28 November 2017

Takushi Yasuda

11

1 reference

28 November 2017

Haruhiko Imamoto

12

1 reference

28 November 2017

Shozo Nishida

13

1 reference

28 November 2017

Yoshifumi Takeyama

14

1 reference

28 November 2017

Hiroshi Furkawa

15

1 reference

28 November 2017

Kiyokata Okuno

16

1 reference

28 November 2017

Hitoshi Shiozaki

17

1 reference

28 November 2017

publication date

17 November 2012

1 reference

28 November 2017

1 reference

28 November 2017

volume

8

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

231-235

1 reference

https://scigraph.springernature.com/pub.10.1007/s11523-012-0239-4

28 November 2017

exact match

0 references

cites work

Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

EpCAM (CD326) finding its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Catumaxomab: clinical development and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

EpCAM: a potential antimetastatic target for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Prowling wolves in sheep's clothing: the search for tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis

21 January 2018

1 reference

12 December 2020

Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases

1 reference

12 December 2020

Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study

1 reference

12 December 2020

Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research

1 reference

12 December 2020

Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4

1 reference

12 December 2020

10.1007/S11523-012-0239-4

Identifiers

DOI

1 reference

28 November 2017

1 reference